ISBSS Seminar Series: Liam Ratcliffe, General Partner, New Leaf Venture Partners
Trends in Biopharmaceutical VC Investing
Liam Ratcliffe is a general partner at New Leaf Venture Partners concentrating on biopharmaceutical investing. Previously, he served as senior vice president and development head for Pfizer Neuroscience, as well as worldwide head of Clinical Research and Development. As head of neurosciences, he was responsible for the development of several successful late-stage projects and marketed products, including Lyrica, Chantix and Geodon. Dr. Ratcliffe earned an M.D. and a Ph.D. from the University of Cape Town and an M.B.A. from the University of Michigan.
Company website: http://www.nlvpartners.com
Dress code: business casual
Contact information: Kathy McNevin, kathryn_mcnevin[at symbol]kgi.edu
|Where:||Bldg. 535, 152 Classroom|
|When:||May 1, 2013, 12:00 p.m. - 1:00 p.m.|